Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda.
M Chantal UmulisaSilvia FranceschiIacopo BaussanoVanessa TenetMathilde UwimbabaziBelson RugwizangogaDaniëlle A M HeidemanAnne M UyterlindeTeresa M DarraghPeter J F SnijdersFelix SayinzogaGary M CliffordPublished in: BMC women's health (2018)
CareHPV was not as sensitive as gold-standard PCR, but detected considerably more hHSIL+ than VIA. However, due to careHPV-positive hHSIL+ women being lost to follow-up and/or triaged to no treatment, 2-visit careHPV+VIA triage did not perform better than VIA screen-and-treat.